China Isotope & Radiation Corporation (HKG:1763)
Hong Kong · Delayed Price · Currency is HKD 13.16
-0.33 (-2.45%)
Sep 11, 2026, 9:50 AM HKT
China Isotope & Radiation Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 7,314 | 7,188 | 7,575 | 6,635 | 6,154 | 5,144 |
Revenue Growth | 1.75% | -5.11% | 14.16% | 7.82% | 19.63% | 20.34% |
Gross Profit Gross Profit Growth | 3,620 | 3,622 | 3,683 | 3,482 | 3,518 | 3,242 |
Operating Income Operating Income Growth | 1,073 | 1,019 | 1,080 | 749.68 | 874.88 | 742.85 |
Net Income Net Income Growth | 325.54 | 327.43 | 406.65 | 370.97 | 392.28 | 335.75 |
Earnings Per Share EPS Growth | 1.02 | 1.02 | 1.27 | 1.16 | 1.23 | 1.05 |
EPS Growth | -0.58% | -19.48% | 9.62% | -5.43% | 16.84% | 57.20% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Nuclear Medicines Nuclear Medicines Growth | 4,116 | 4,020 | 4,171 | 4,132 | 3,925 | 3,755 |
Radioactive Sources and Application Radioactive Sources and Application Growth | 1,015 | 835.65 | 745.81 | 638.08 | 618.44 | 554.83 |
Irradiation Application Irradiation Application Growth | 217.58 | 191.3 | 200.33 | 178.56 | 171.33 | 144.25 |
Nuclear Medical Equipment and Related Services Nuclear Medical Equipment and Related Services Growth | 717.52 | 601.55 | 1,231 | 940.71 | 739.98 | 404.22 |
Other Businesses Other Businesses Growth | 1,514 | 1,602 | 1,306 | 816.48 | 755.24 | - |
Elimination of Inter-Segment Elimination of Inter-Segment Growth | - | -62.82 | -79.67 | -71.1 | -56.49 | -52.36 |
Total Total Growth | 7,314 | 7,188 | 7,575 | 6,635 | 6,154 | 5,144 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,554 | 2,620 | 2,681 | 2,941 | 2,979 | 2,789 |
Total Debt Total Debt Growth | 2,945 | 2,739 | 2,572 | 1,702 | 903.86 | 856.63 |
Net Cash (Debt) Net Cash Growth | -391.05 | -118.84 | 108.93 | 1,239 | 2,076 | 1,932 |
Net Cash Growth | - | - | -91.21% | -40.30% | 7.42% | 4.76% |
Net Cash Per Share Net Cash Per Share Growth | -1.22 | -0.37 | 0.34 | 3.87 | 6.49 | 6.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 785.6 | 538.34 | 142.48 | 84.96 | 863.12 | 794.31 |
Capital Expenditures CapEx Growth | -586.96 | -566.77 | -1,032 | -897.62 | -576.38 | -427.72 |
Free Cash Flow Free Cash Flow Growth | 198.64 | -28.43 | -889.71 | -812.66 | 286.74 | 366.59 |
Free Cash Flow Growth | - | - | - | - | -21.78% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 49.49% | 50.39% | 48.62% | 52.48% | 57.16% | 63.03% |
Operating Margin | 14.67% | 14.18% | 14.26% | 11.30% | 14.22% | 14.44% |
Pretax Margin | 14.37% | 13.97% | 13.80% | 13.90% | 14.96% | 15.61% |
Profit Margin | 4.45% | 4.55% | 5.37% | 5.59% | 6.38% | 6.53% |
FCF Margin | 2.72% | -0.40% | -11.75% | -12.25% | 4.66% | 7.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.359 | 0.307 | 0.381 | 0.313 | 0.441 | 0.378 |
Dividend Per Share Growth | -11.49% | -19.48% | 21.81% | -28.95% | 16.62% | 109.59% |
Dividend Yield | 2.51% | 1.72% | 3.91% | 2.81% | 4.19% | 2.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.48 | 17.73 | 8.03 | 10.46 | 9.65 | 17.08 |
Forward PE | - | 10.90 | 10.90 | 10.90 | 8.92 | 14.11 |
P/FCF Ratio | 18.82 | - | - | - | 13.20 | 15.64 |
PS Ratio | 0.51 | 0.81 | 0.43 | 0.59 | 0.62 | 1.12 |